6 results
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
End Points #EBM #Neuro ... #IM #Fremanezumab ... #Migraine #CGRP ... CalcitoninGeneRelatedPeptideAntibody #Results #NEJM ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Adverse Events in the Safety Population, According
Trial Group #EBM #Neuro ... #IM #Fremanezumab ... #Migraine #CGRP ... AdverseEvents #NEJM ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Treatment of Chronic Migraine ... End Points #EBM #Neuro ... #IM #Fremanezumab ... #Migraine #CGRP ... CalcitoninGeneRelatedPeptideAntibody #NEJM
Pathogenesis of Nonalcoholic Steatohepatitis. Various factors, including inflammation, hyperinsulinemia or insulin resistance, and altered lipid homeostasis,
hyperinsulinemia or insulin resistance ... Pathophysiology #GI #IM ... NonAlcoholicFattyLiverDisease #NEJM
Nephron Remodeling as a Mechanism of Diuretic Resistance. When high doses of loop diuretics are used
Mechanism of Diuretic Resistance ... Pathophysiology #Nephro #IM ... #LoopDiuretic #Resistance ... NephronRemodeling #NEJM
Mechanisms of Loop Diuretic Action and Resistance. Panel A, loop diuretics circulate bound to protein. As
Diuretic Action and Resistance ... mediate diuretic resistance ... Pathophysiology #Nephro #IM ... MechanismOfAction #Resistance ... #NEJM